Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,607 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $354.30 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $336.81 | 15 | $0 (2024) |
| Novo Nordisk Inc | $305.79 | 17 | $0 (2024) |
| Amgen Inc. | $290.75 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $268.36 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $201.19 | 12 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $189.95 | 8 | $0 (2024) |
| Abbott Laboratories | $135.03 | 6 | $0 (2024) |
| Dexcom, Inc. | $104.70 | 6 | $0 (2024) |
| Axsome Therapeutics, Inc. | $84.09 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $620.47 | 33 | ABBVIE INC. ($149.57) |
| 2023 | $1,041 | 63 | AbbVie Inc. ($182.76) |
| 2022 | $744.00 | 41 | Amgen Inc. ($188.71) |
| 2021 | $200.92 | 6 | AstraZeneca Pharmaceuticals LP ($122.55) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Neurology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Obesity | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardio-renal | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes Care | ||||||
| 07/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Obesity | ||||||
| 06/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $41.03 | General |
| Category: NEUROLOGY | ||||||
| 05/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Endocrinology | ||||||
| 05/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes Care | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Neurology | ||||||
| 03/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes Care | ||||||
| 03/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 171 | 499 | $61,095 | $24,308 |
| 2022 | 5 | 137 | 430 | $49,705 | $20,759 |
| 2021 | 1 | 11 | 16 | $3,200 | $1,589 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 248 | $49,600 | $20,923 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,100 | $1,790 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $2,295 | $1,072 | 46.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 58 | $2,320 | $495.01 | 21.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 21 | 56 | $280.00 | $20.80 | 7.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 100 | $500.00 | $7.75 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 201 | $40,200 | $18,327 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,115 | $2,032 | 28.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 39 | $1,560 | $373.72 | 24.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 13 | 34 | $170.00 | $16.44 | 9.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 18 | 132 | $660.00 | $9.66 | 1.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 16 | $3,200 | $1,589 | 49.7% |
About Dr. Thomas Brimer, MD
Dr. Thomas Brimer, MD is a Internal Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1467957993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Brimer, MD has received a total of $2,607 in payments from pharmaceutical and medical device companies, with $620.47 received in 2024. These payments were reported across 143 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,607).
As a Medicare-enrolled provider, Brimer has provided services to 319 Medicare beneficiaries, totaling 945 services with total Medicare billing of $46,657. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Fort Myers, FL
- Active Since 03/27/2018
- Last Updated 02/05/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467957993
Products in Payments
- VRAYLAR (Drug) $269.64
- BREZTRI (Drug) $257.58
- Kerendia (Drug) $201.19
- REXULTI (Drug) $189.95
- TRELEGY ELLIPTA (Drug) $180.87
- Ozempic (Drug) $136.85
- Rybelsus (Drug) $132.50
- Otezla (Drug) $132.06
- Dexcom G6 Transmitter (Medical Supply) $104.70
- Repatha (Biological) $102.80
- Sunosi (Drug) $84.09
- SHINGRIX (Biological) $68.68
- FREESTYLE LIBRE 3 (Device) $66.63
- MOUNJARO (Drug) $62.71
- Aimovig (Biological) $55.89
- AIRSUPRA (Drug) $46.81
- FREESTYLE LIBRE 2 (Device) $43.90
- GVOKE HYPOPEN (Drug) $41.61
- INSPIRE (Device) $41.03
- UBRELVY (Drug) $40.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Myers
Dr. Michael Oleksyk, Md, MD
Internal Medicine — Payments: $570,596
Dr. Malissa Wood, Md, MD
Internal Medicine — Payments: $377,298
Oliver Abela, Md, MD
Internal Medicine — Payments: $70,958
Francisco De Jesus Paulino, Md, MD
Internal Medicine — Payments: $50,407
Dr. Vinayak Thakur, M.d, M.D
Internal Medicine — Payments: $19,038
Imtiaz Ahmad, Md, MD
Internal Medicine — Payments: $18,331